Compare MRVI & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | ACNB |
|---|---|---|
| Founded | 2014 | 1857 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 559.0M | 547.0M |
| IPO Year | 2020 | 1994 |
| Metric | MRVI | ACNB |
|---|---|---|
| Price | $4.82 | $54.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.13 | ★ $58.00 |
| AVG Volume (30 Days) | ★ 2.6M | 37.0K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.00% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ 1.32 |
| Revenue | $185,743,000.00 | ★ $191,821,000.00 |
| Revenue This Year | $12.54 | $13.18 |
| Revenue Next Year | $7.87 | $1.91 |
| P/E Ratio | ★ N/A | $41.22 |
| Revenue Growth | N/A | ★ 45.10 |
| 52 Week Low | $1.99 | $40.21 |
| 52 Week High | $5.00 | $55.55 |
| Indicator | MRVI | ACNB |
|---|---|---|
| Relative Strength Index (RSI) | 68.22 | 60.61 |
| Support Level | $3.27 | $42.97 |
| Resistance Level | $5.00 | N/A |
| Average True Range (ATR) | 0.25 | 1.14 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 81.91 | 68.26 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
ACNB Corp is the financial holding company. Through its wholly-owned subsidiaries, it provides a full range of retail and commercial financial services in Pennsylvania and Maryland through its network of community banking offices. It also provides property, casualty, health, life and disability insurance serving personal and commercial clients through offices in Westminster, Maryland, and Gettysburg, Pennsylvania and is licensed to do business. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage; and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.